Page last updated: 2024-10-22

amiodarone and Amyloid Neuropathies, Familial

amiodarone has been researched along with Amyloid Neuropathies, Familial in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Amyloid Neuropathies, Familial: Inherited disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. The different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin (PREALBUMIN); APOLIPOPROTEIN A-I; and GELSOLIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Oladiran, O1
Oladunjoye, A1
Oladunjoye, OO1
Paudel, A1
Oke, I1
Motz, L1
Luber, S1
Licata, A1

Other Studies

1 other study available for amiodarone and Amyloid Neuropathies, Familial

ArticleYear
Sustained Ventricular Tachycardia as a Harbinger of Cardiac Amyloidosis.
    The American journal of case reports, 2020, Dec-07, Volume: 21

    Topics: Aged; Amiodarone; Amyloid Neuropathies, Familial; Defibrillators, Implantable; Electric Countershock

2020